Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 1/2012

01-01-2012 | Rhinology

The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma

Authors: S. K. Haerle, M. B. Soyka, D. R. Fischer, K. Murer, K. Strobel, G. F. Huber, D. Holzmann

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2012

Login to get access

Abstract

The aim this study was to evaluate imaging findings using position emission tomography (PET) in combination with computed tomography (CT) and 18F-fluorodeoxyglucose (18F-FDG) in sinonasal malignant melanoma (SNMM) of the head and neck in a retrospective analysis of a consecutive cohort of patients. 18F-FDG-PET/CT examinations were performed for initial staging and compared with CT or magnetic resonance tomography (MRI), and 18F-FDG-PET alone. Medical records were reviewed retrospectively with regard to the location and the size of the tumor. Furthermore, locoregional and distant metastases with a consecutive change in therapy detected by 18F-FDG-PET/CT were assessed. Ten patients suffering from sinonasal malignant melanoma were staged and followed by 18F-FDG-PET/CT imaging. A total of 34 examinations were obtained. 18F-FDG-PET/CT depicted all primary tumors adequately. Aside from one cerebral metastasis all regional and distant metastases were truly identified by using this method. In summary, if available, 18F-FDG-PET/CT is a valuable imaging modality for staging and re-staging sinonasal malignant melanoma to evaluate expansion of the primary tumor, locoregional disease, and distant metastases.
Literature
1.
Chang A, Karnell L, Menck H (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84, 836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1664–1678PubMedCrossRef
2.
Andersen L, Berthelsen A, Hansen H (1992) Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 21:180–185PubMed
3.
Thompson L, Wieneke J, Miettinen M (2003) Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 27:594–611PubMedCrossRef
4.
Steinert H, Huch Böni R, Buck A et al (1995) Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology 195:705–709PubMed
5.
Goerres G, Stoeckli S, von Schulthess G, Steinert H (2002) FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 112:381–385PubMedCrossRef
6.
Chiu N, Weinstock M (1996) Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg 122:985–988PubMedCrossRef
7.
Roth TN, Gengler C, Huber GF, Holzmann D (2010) Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 32(10):1385–1392
8.
Lengyel E, Gilde K, Remenár E, Esik O (2003) Malignant mucosal melanoma of the head and neck. Pathol Oncol Res 9:7–12PubMedCrossRef
9.
Brandwein M, Rothstein A, Lawson W, Bodian C, Urken M (1997) Sinonasal melanoma. A clinicopathologic study of 25 cases and literature meta-analysis. Arch Otolaryngol Head Neck Surg 123:290–296PubMedCrossRef
10.
Swetter S, Carroll L, Johnson D, Segall G (2002) Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 9:646–653PubMedCrossRef
11.
Strobel K, Dummer R, Husarik D, Pérez Lago M, Hany T, Steinert H (2007) High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology 244:566–574PubMedCrossRef
12.
Strobel K, Skalsky J, Steinert H et al (2007) S-100B and FDG-PET/CT in therapy response assessment of melanoma patients. Dermatology 215:192–201PubMedCrossRef
13.
Reinhardt M, Joe A, Jaeger U et al (2006) Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 24:1178–1187PubMedCrossRef
14.
Gulec S, Faries M, Lee C et al (2003) The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making. Clin Nucl Med 28:961–965PubMedCrossRef
15.
Von Schulthess G, Hany T (2008) Imaging and PET–PET/CT imaging. J Radiol 89:438–447 (quiz 48)
16.
Veit-Haibach P, Vogt F, Jablonka R et al (2009) Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging 36:910–918PubMedCrossRef
17.
Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK (1996) Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23:737–743PubMedCrossRef
18.
Hollenbeak CS, Lowe VJ, Stack BC Jr (2001) The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer 92:2341–2348PubMedCrossRef
19.
Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med 51:176–182PubMedCrossRef
20.
Goerres G, Von Schulthess G, Hany T (2002) Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR Am J Roentgenol 179:1337–1343PubMed
21.
Yousem D, Li C, Montone K et al (1996) Primary malignant melanoma of the sinonasal cavity: MR imaging evaluation. Radiographics 16:1101–1110PubMed
22.
Yoshioka H, Kamada T, Kandatsu S et al (1998) MRI of mucosal malignant melanoma of the head and neck. J Comput Assist Tomogr 22:492–497PubMedCrossRef
23.
Uchiyama Y, Murakami S, Kawai T, Ishida T, Fuchihata H (1998) Primary malignant melanoma in the oral mucosal membrane with metastasis in the cervical lymph node: MR appearance. AJNR Am J Neuroradiol 19:954–955PubMed
Metadata
Title
The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma
Authors
S. K. Haerle
M. B. Soyka
D. R. Fischer
K. Murer
K. Strobel
G. F. Huber
D. Holzmann
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2012
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-011-1664-1

Other articles of this Issue 1/2012

European Archives of Oto-Rhino-Laryngology 1/2012 Go to the issue

Otology

Cupulolithiasis of the horizontal semicircular canal

Head and Neck

Bilateral synchronous tonsillar carcinoma: a case series and review of the literature

Otology

Sensation recovery of auricle following chronic ear surgery by retroauricular incision

Letter to the Editor

Is it possible to measure peripheral vestibular function in a patient with congenital nystagmus?

Otology

Analysis of psychological distress after management of dizziness in old patients: multicenter study

Head and Neck

The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy